Clinical trials recruiting in Wangen, Germany
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 7Not applicable 2
Conditions recruiting in Wangen, Germany
Recruiting trials in Wangen, Germany
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Register Schweres Asthma - German Asthma Net e.V.
- TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Common questions
How many clinical trials are recruiting in Wangen, Germany?
9 recruiting trials have at least one study site in Wangen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.